DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers

[1]  S. Weitzman,et al.  Mapping of ER gene CpG island methylation-specific polymerase chain reaction. , 1998, Cancer research.

[2]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[3]  V. Jordan,et al.  Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. , 1998, British Journal of Cancer.

[4]  S. Baylin,et al.  Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2′deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells* , 1997, The Journal of Biological Chemistry.

[5]  J. Herman,et al.  Association between CpG island methylation and microsatellite instability in colorectal cancer. , 1997, Cancer research.

[6]  T. Kurihara,et al.  Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. , 1997, Carcinogenesis.

[7]  C. Mathew,et al.  Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. , 1996, Cancer letters.

[8]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[9]  W. Birchmeier,et al.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. , 1995, Oncogene.

[10]  M. Dowsett,et al.  Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. , 1995, Cancer research.

[11]  S. Baylin,et al.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.

[12]  J. Gustafsson,et al.  Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. , 1995, Endocrinology.

[13]  N. Roodi,et al.  Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. , 1995, Journal of the National Cancer Institute.

[14]  C. Mathew,et al.  Loss of heterozygosity of the oestrogen receptor gene in breast cancer. , 1995, British Journal of Cancer.

[15]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[16]  G. T. Budd,et al.  Estrogen receptor mutations in tamoxifen-resistant breast cancer. , 1994, Cancer research.

[17]  R. Sutherland,et al.  Oestrogen receptor gene structure and function in breast cancer , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  W. McGuire,et al.  Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.

[19]  W. McGuire,et al.  Estrogen receptor gene methylation in human breast tumors. , 1990, Cancer research.